Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?

Severe Acute Respiratory Distress Syndrome caused by a novel human coronavirus SARS-CoV-2 named COVID-19 and declared as a pandemic. This paper reviews the possibility of repurposing angiotensin type 1 receptor (AT1R) antagonists and vitamin D to treat COVID-19. ACE2 protein found on the cell membra...

Descripción completa

Detalles Bibliográficos
Autor principal: Rafiullah, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Southern Society for Clinical Investigation. Published by Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362851/
https://www.ncbi.nlm.nih.gov/pubmed/32736832
http://dx.doi.org/10.1016/j.amjms.2020.07.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362851/
https://www.ncbi.nlm.nih.gov/pubmed/32736832
http://dx.doi.org/10.1016/j.amjms.2020.07.018

Ejemplares similares